Correlation Between Syros Pharmaceuticals and Surrozen

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Syros Pharmaceuticals and Surrozen at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Syros Pharmaceuticals and Surrozen into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Syros Pharmaceuticals and Surrozen, you can compare the effects of market volatilities on Syros Pharmaceuticals and Surrozen and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Syros Pharmaceuticals with a short position of Surrozen. Check out your portfolio center. Please also check ongoing floating volatility patterns of Syros Pharmaceuticals and Surrozen.

Diversification Opportunities for Syros Pharmaceuticals and Surrozen

0.38
  Correlation Coefficient

Weak diversification

The 3 months correlation between Syros and Surrozen is 0.38. Overlapping area represents the amount of risk that can be diversified away by holding Syros Pharmaceuticals and Surrozen in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Surrozen and Syros Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Syros Pharmaceuticals are associated (or correlated) with Surrozen. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Surrozen has no effect on the direction of Syros Pharmaceuticals i.e., Syros Pharmaceuticals and Surrozen go up and down completely randomly.

Pair Corralation between Syros Pharmaceuticals and Surrozen

Given the investment horizon of 90 days Syros Pharmaceuticals is expected to under-perform the Surrozen. In addition to that, Syros Pharmaceuticals is 2.65 times more volatile than Surrozen. It trades about -0.11 of its total potential returns per unit of risk. Surrozen is currently generating about 0.0 per unit of volatility. If you would invest  999.00  in Surrozen on August 26, 2024 and sell it today you would lose (84.00) from holding Surrozen or give up 8.41% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Syros Pharmaceuticals  vs.  Surrozen

 Performance 
       Timeline  
Syros Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Syros Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in December 2024. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.
Surrozen 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Surrozen are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of very unfluctuating basic indicators, Surrozen may actually be approaching a critical reversion point that can send shares even higher in December 2024.

Syros Pharmaceuticals and Surrozen Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Syros Pharmaceuticals and Surrozen

The main advantage of trading using opposite Syros Pharmaceuticals and Surrozen positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Syros Pharmaceuticals position performs unexpectedly, Surrozen can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Surrozen will offset losses from the drop in Surrozen's long position.
The idea behind Syros Pharmaceuticals and Surrozen pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.

Other Complementary Tools

Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Transaction History
View history of all your transactions and understand their impact on performance
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Bonds Directory
Find actively traded corporate debentures issued by US companies
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine